Close
Almac
Achema middle east

News

Baris Erdogan succeeds Ian Rentsch as CEO of Clinerion

Baris Erdogan, currently Vice President, Site & Patient Networks, at Clinerion, has been promoted by the Board of Directors to the position of Chief Executive Officer as of January 1st, 2021. After a three-year tenure, Clinerion’s current CEO, Ian...

SkyCell introduces revolutionary new deep frozen container – The 1500DF

At SkyCell, we are always striving for safer and more efficient ways to transport life-saving medicines around the world. With this mission in mind, our passionate team of engineers has developed a revolutionary new container: The SkyCell 1500 DF. SkyCell’s...

Kaye Introduces the Kaye Log -80 Vaccine Temperature Logger for Cold Chain Market to Address COVID-19 Vaccine Storage and Transportation Requirements

Kaye has been a leader for over 60 years in the Validation and Monitoring of critical process data. With its introduction of the Kaye Log -80 Vaccine Temperature Logger and KayeTrack Cloud Kaye has applied the same quality principles...

Samsung Biologics Names John Rim as President and CEO

Samsung Biologics announced John Rim as its President and CEO. The appointment was made effective immediately and formalized via the company’s board of directors meeting today. Prior to being appointed CEO, John served as Executive Vice President at Samsung Biologics...

Singapore approves Pfizer and BioNTech’s Covid-19 vaccine

Singapore has approved the Covid-19 vaccine by Pfizer and its German partner BioNTech, as well as expects delivery of the first shots by December-end. Singapore is the first Asian country to approve the vaccine, Reuters reported. The free vaccines will...

Merck Keytruda Gets CHMP Nod for First-Line Colon Cancer

Merck & Co., Inc. MRK announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (“CHMP”) issued a positive opinion to the Marketing Authorization Application (“MAA”) for its blockbuster drug, Keytruda for expanded use. The MAA...

Gavi, the Vaccine Alliance, Collaborates with Salesforce to Help Equitably Distribute Two Billion COVID-19 Vaccines by the End of 2021

Salesforce, the global leader in CRM, and Gavi, the Vaccine Alliance, announced that they will collaborate to help Gavi manage critical information to equitably distribute approximately two billion COVID-19 vaccines to 190 countries by the end of 2021. Fair, rapid...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »